IXEKIZUMAB
Tracking # 20-817391
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
IXEKIZUMAB IS FDA-INDICATED FOR THE ADULT TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS. THESE ADULT PATIENTS ARE ALSO CANDIDATES FOR SYSTEMIC THERAPY OR PHOTOTHERAPY. SAFETY AND EFFECTIVENESS HAVE NOT BEEN DETERMINED IN PEDIATRIC PATIENTS. PSORIASIS WILL BE BRIEFLY DISCUSSED TO BECOME FAMILIAR WITH IXEKIZUMAB'S MECHANISM OF ACTION AND ITS THERAPEUTIC USE. THIS ACTIVITY HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING PATIENTS PRESCRIBED IXEKIZUMAB FOR PSORIASIS.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I